top of page
DSC_2149_edited.jpg

Latest News

We help inventions grow!

Dec 23, 2022

We are looking for new Antonin Holy and new drugs and diagnostics that can have a global impact and success

"i&i Bio invests in technology transfer with a strong focus on healthcare. We look for unique technologies that come from Czech and foreign science. We always try to find something new and unique, something that could bring great benefit to patients and also to our investors," says Jaromír Zahrádka for Fintag.cz. The podcast is in the Czech language.

sklo jaromir_mensi.jpg

Sep 28, 2022

Smart bandages not only capture pathogens, but also destroy them in no time. All they need is ordinary light.

Hospital-acquired infections are a problem that current technologies are not able to deal with effectively. However, this could change in the future; the Czech spin-off LAM-X a.s. is working on the development of a nanomaterial that not only passively prevents pathogens from entering open wounds, but can also actively destroy them ...

lamx tym.jpg

Sep 13, 2022

CasInvent Pharma raises €1.3M from KHAN-I and i&i Bio for the development of CK1 inhibitors for the treatment of cancers

CasInvent Pharma, an early-stage drug discovery company developing small-molecule compounds with anticancer properties, has raised an investment round of €1.3 million provided by KHAN-I and i&i Bio. With this funding, CasInvent will be strengthening its portfolio of CK inhibitors and progressing its lead compound to ...

Kamil Paruch with colleagues.jpg

Aug 22, 2022

Jaromír Zahrádka: Investments help science to serve people

According to Jaromír Zahrádka, director of the i&i Biotech investment fund, investing in science is like the proverbial chicken and egg. If there is a lack of investment, no new projects are created. And without interesting projects, it is impossible to get investors interested. So how to solve this dilemma?

jaromir zahardka_mensi.jpg

i&i Prague Highlights

Highlights from i&i Bio

We have moved the investment part of our business to our associated venture capital firm, i&i Biotech Fund I. Here you can find the most important news from (i&i Bio).

The Advisory Committee of i&i Biotech Fund strengthened by renowned economist Daniel Münich

Jan 4, 2023

i&i Biotech Fund announces the launch of cooperation with Associate Professor Daniel Münich, who has joined the Fund's Advisory Committee. The renowned Czech economist will join the European Investment Fund's (EIF) delegate as a representative of the bio-innovation center, i&i Prague, ...

i&i Bio invests more than €1 M in Enzyre to help to advance pioneering diagnostic technology platform for hemophilia patients

Nov 30, 2022

Leading Czech businessmen have joined the support of the most promising scientific projects. Eight prominent entrepreneurs have contributed nearly €2 million to the i&i Biotech Fund (i&i Bio), an investment fund that specializes in finding and developing unique academic startups ...

i&i Bio invests more than €1 M in Enzyre to help to advance pioneering diagnostic technology platform for hemophilia patients

Nov 2, 2022

Enzyre, a company developing a breakthrough ambulant diagnostic technology for blood coagulation testing, today announced that it has successfully raised EUR 12 million Series A funding led by new investor Oost NL, with participation from i&i Biotech Fund, Demcon Investment ...

Nanoligent raised €2.8 M and completed Seed round financing with support of i&i Biotech Fund I

Sep 27, 2022

Nanoligent SL, a Spanish biotech company specialized in the development of cancer treatments based on unique protein conjugates, today announces the completion of a Seed financing round of total € 2.8 M. The final closing of the Seed round consists of € 1 M investment by i&i Biotech Fund I ...

Other news

Our notes from a trip to “The most startup friendly country in the whole world”
The judges at Transfera Technology Day 2021 awarded the cream of the crop
 
i&i Bio, the newly estabilished investment fund powered by i&i Prague and EIF
Licensing agreement for a novel SARS Cov-2 virus neutralization antibody test was signed
Spin-off Enantis concluded a license agreement for the production of stabilised growth factor FGF2
CasInvent Pharma, an University Spin-Off Focused on Developing Cancer Drugs Established with Help of i&i Prague!
UCT Prague, a Czech leading chemistry-focused University, entered in memorandum with i&i Prague, s.r.o.
Elphogene received a TA CR grant for “Sample prep system and technology for cancer testing by liquid biopsy”!
i&i Prague announces its first exit, DIANA Biotechnologies is bought out by its founders
Spin-off CasInvent Pharma receives the Neuron Award for excellent Technology Transfer
i&i Prague supports the innovative PEP-Therapy in their extension of the Series-A financing, totalling €5.4 million...
Green chemistry start-up Sulfotools closes seed round with the bio-innovation centre i&i Prague
i&i Prague supported start-up LAM-X a.s. won the 2020 EIT Health MedTech Bootcamp final Pitch Event
PerioTrap Pharmaceuticals Raises €3M Seed Round to Develop Selective Anti-infectives to Tackle Periodontitis
Dracen Announces the Initiation of First-in-human Study of DRP-104 in Adult Patients With Advanced Solid Tumors!
bottom of page